Article
Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever.
Modern rheumatology - 1 Jul 2016
Hamanoue Satoshi, Suwabe Tatsuya, Hoshino Junichi, Sumida Keiichi, Mise Koki, Hayami Noriko, Sawa Naoki, Takaichi Kenmei, Fujii Takeshi, Ohashi Kenichi, Yazaki Masahide, Ikeda Shuichi, Ubara Yoshifumi
Abstract excerpt
Familial Mediterranean fever (FMF) is a well-known cause of secondary AA amyloidosis. Colchicine is generally considered to be the most effective treatment for FMF and FMF-associated amyloidosis, but the management of patients who are refractory to colchicine remains controversial. We encountered...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
